NovImmune

NovImmmune develops therapeutic monoclonal antibodies to treat patients suffering from immune-related disorders.

Founded

1998

Raised

$137.2M

Follow us

Also headquartered in Geneva

Companies in the same industry

Alexa global traffic share

Built with ❤︎ by Datalicious ©2020
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Add info

Add round

17 Dec 2010

$22,413,980

Venture capital (Series D)

BZ Bank

12 May 2009

$54,800,000

Venture capital (Series C)

Novartis Venture Fund, Aravis Ventures, BZ Bank, +4

01 Jun 2006

$46,000,000

Venture capital (Series B)

Novartis Venture Fund, Aravis Ventures, BZ Bank, +2

01 May 2000

$14,000,000

Venture capital (Series A)

Novartis Venture Fund, LODH Immunology Fund